Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder

Last updated: March 9, 2026
Sponsor: University of Utah
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sleep Disorders

Treatment

Cognitive Behavioral Therapy for Nightmares

Clinical Study ID

NCT06441864
00187090
09-SRG-23
  • Ages > 18
  • All Genders

Study Summary

The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD). People with RBD will be enrolled in the study along with their family members (a partner or other family member residing in the same home). All participants will receive the treatment via videoconference and will complete 2 assessments. Participants with RBD will attend 7 sessions, and their family members will attend 2 of those sessions with them.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of isolated RBD or RBD secondary to neurodegenerative disease

  • Age 18 or older

  • Speak, read, and write English

  • Live in the United States

  • Nightmare frequency ≥3 times per week

  • Disturbing Dream and Nightmare Severity Index score indicative of nightmare disorder

  • Sleep, neurological, and psychiatric medications stable for at least 1 month andwilling to keep medications stable through the course of the study

  • Live with a family member who is willing to participate in the study

Exclusion

Exclusion Criteria:

  • Possible dementia

  • Narcolepsy

  • Posttraumatic stress disorder

  • Previous behavioral treatment for nightmares

  • Currently engaged in sleep- or trauma-focused psychotherapy

  • Taking a medication that could cause RBD, if the medication was started prior toonset of RBD symptoms

Inclusion Criteria (Family Members):

  • Live with a family member who meets all of the above criteria

  • Age 18 or older

  • Speak, read, and write English

  • Live in the United States

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Cognitive Behavioral Therapy for Nightmares
Phase:
Study Start date:
July 15, 2024
Estimated Completion Date:
December 01, 2026

Connect with a study center

  • Northwestern University

    Chicago, Illinois 60611
    United States

    Site Not Available

  • University of Utah

    Salt Lake City, Utah 84108
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.